IA SF2421: A bill for an act relating to utilization review organizations' use of artificial intelligence, prior authorization determinations and exemptions, an…
Verified
Get emailed when this bill changes status, is amended, or advances.
Disclaimer: This page provides general informational summaries only and does not constitute legal advice. AI-generated content may contain errors. Always consult a qualified attorney for guidance specific to your situation.
Read full disclaimer →
A bill for an act relating to utilization review organizations' use of artificial intelligence, prior authorization determinations and exemptions, and audits, and including applicability provisions.(Formerly SSB 3118.)
AI Summary
This bill regulates AI use in prior authorization by UROs, ensuring human oversight in denials and exemptions for cancer screenings.
If you operate a utilization review organization in Iowa, you must ensure AI is not the sole basis for denying prior authorizations by January 1, 2027.
State
Iowa
Bill Number
SF2421
Status
Introduced
Risk Level
High
Category
Comprehensive
Effective Date
Jan 1, 2027
Last Action
Mar 4, 2026
Last Verified
May 24, 2026
Data Updated
May 24, 2026
What do these statuses mean?▼
Introduced— Filed in the legislature; not yet heard in committee
In Committee— Assigned to and being reviewed by a legislative committee
Passed— Approved by one or both chambers; awaiting further action
Signed / Enacted— Signed into law by the governor; may or may not be in effect yet
Dead / Vetoed— Vetoed, failed to pass, or session expired without action
Unknown— Status data not yet available or awaiting classification
Senate File 2421 introduces regulations on how utilization review organizations can use artificial intelligence in prior authorization processes. It mandates that AI cannot solely determine the denial or downgrade of requests based on medical necessity. This bill impacts healthcare providers and insurers, ensuring that human expertise is involved in critical healthcare decisions and exempts cancer-related screenings from prior authorization.
Key Provisions
UROs may use AI for initial reviews but not as the sole basis for denials based on medical necessity.
Denials or downgrades must be made by qualified reviewers or clinical peers.
Written notifications must be provided to healthcare providers detailing reasons for denials.
Consultations must occur within seven business days after a denial.
The bill applies to prior authorization requests made before and after January 1, 2027.
Cancer-related screenings recommended by healthcare professionals are exempt from prior authorization.
Latest Legislative Action
Withdrawn. S.J. 475.
Bill Sponsors
Name
Role
Health And Human Services
Sponsor
Roll Call Votes
S ·
Senate Commerce Report ·
Mar 3, 2026
16 Yea 0 Nay 3 OtherPassed ✓
S ·
Senate Health And Human Services Report ·
Feb 23, 2026
17 Yea 0 Nay 1 OtherPassed ✓
Compliance Checklist
Ensure AI is not the sole basis for prior authorization decisions. Who: Utilization review organizations. Deadline: By January 1, 2027. Penalty: Claims may be automatically approved if not compliant.
Provide written notifications for any denials or downgrades. Who: Utilization review organizations. Deadline: Within seven business days of a decision. Penalty: Failure to notify may lead to automatic approval of claims.
Senate File 2421 establishes guidelines for the use of artificial intelligence by utilization review organizations (UROs) in Iowa. It permits UROs to use AI algorithms for initial reviews of prior authorization requests but prohibits using AI as the sole basis for decisions that deny, delay, or downgrade requests based on medical necessity. The bill requires that any denial or downgrade must be made by a qualified reviewer or clinical peer, ensuring that healthcare professionals with relevant expertise are involved in these critical decisions. The bill also outlines specific requirements for written notifications to healthcare providers regarding denials, including the reasons for the decision and the appeals process. Additionally, it mandates a consultation between the healthcare provider and a qualified reviewer or clinical peer within seven business days after a denial. The bill exempts cancer-related screenings recommended by healthcare professionals from prior authorization requirements. The bill applies to all prior authorization requests made before and after January 1, 2027, ensuring that organizations comply with these new standards. This legislation aligns with ongoing trends in healthcare regulation, emphasizing the importance of human oversight in automated decision-making processes, particularly in sensitive areas like healthcare. Overall, this bill represents a significant step in regulating the intersection of artificial intelligence and healthcare, aiming to protect patients and ensure that decisions affecting their care are made with appropriate human involvement.
We use cookies for analytics to understand how visitors use this site. We also use essential cookies for site functionality.
See our Privacy Policy for details.